<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39457994</PMID><DateRevised><Year>2024</Year><Month>10</Month><Day>28</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2077-0383</ISSN><JournalIssue CitedMedium="Print"><Volume>13</Volume><Issue>20</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>10</Day></PubDate></JournalIssue><Title>Journal of clinical medicine</Title><ISOAbbreviation>J Clin Med</ISOAbbreviation></Journal><ArticleTitle>Rapid and Robust Identification of Sepsis Using SeptiCyte RAPID in a Heterogeneous Patient Population.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">6044</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/jcm13206044</ELocationID><Abstract><AbstractText><b>Background/Objective:</b> SeptiCyte RAPID is a transcriptional host response assay that discriminates between sepsis and non-infectious systemic inflammation (SIRS) with a one-hour turnaround time. The overall performance of this test in a cohort of 419 patients has recently been described [Balk et al., J Clin Med 2024, 13, 1194]. In this study, we present the results from a detailed stratification analysis in which SeptiCyte RAPID performance was evaluated in the same cohort across patient groups and subgroups encompassing different demographics, comorbidities and disease, sources and types of pathogens, interventional treatments, and clinically defined phenotypes. The aims were to identify variables that might affect the ability of SeptiCyte RAPID to discriminate between sepsis and SIRS and to determine if any patient subgroups appeared to present a diagnostic challenge for the test. <b>Methods:</b> (1) Subgroup analysis, with subgroups defined by individual demographic or clinical variables, using conventional statistical comparison tests. (2) Principal component analysis and k-means clustering analysis to investigate phenotypic subgroups defined by unique combinations of demographic and clinical variables. <b>Results:</b> No significant differences in SeptiCyte RAPID performance were observed between most groups and subgroups. One notable exception involved an enhanced SeptiCyte RAPID performance for a phenotypic subgroup defined by a combination of clinical variables suggesting a septic shock response. <b>Conclusions:</b> We conclude that for this patient cohort, SeptiCyte RAPID performance was largely unaffected by key variables associated with heterogeneity in patients suspected of sepsis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Balk</LastName><ForeName>Robert</ForeName><Initials>R</Initials><Identifier Source="ORCID">0000-0001-5757-2649</Identifier><AffiliationInfo><Affiliation>Rush Medical College and Rush University Medical Center, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Esper</LastName><ForeName>Annette M</ForeName><Initials>AM</Initials><AffiliationInfo><Affiliation>Grady Memorial Hospital and Emory University School of Medicine, Atlanta, GA 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Martin</LastName><ForeName>Greg S</ForeName><Initials>GS</Initials><Identifier Source="ORCID">0000-0002-9684-7593</Identifier><AffiliationInfo><Affiliation>Grady Memorial Hospital and Emory University School of Medicine, Atlanta, GA 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Miller</LastName><ForeName>Russell R</ForeName><Initials>RR</Initials><Suffix>3rd</Suffix><AffiliationInfo><Affiliation>FirstHealth of the Carolinas, Pinehurst, NC 28374, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lopansri</LastName><ForeName>Bert K</ForeName><Initials>BK</Initials><AffiliationInfo><Affiliation>Intermountain Medical Center, Murray, UT 84107, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University of Utah, Salt Lake City, UT 84132, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Burke</LastName><ForeName>John P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Intermountain Medical Center, Murray, UT 84107, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>School of Medicine, University of Utah, Salt Lake City, UT 84132, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Levy</LastName><ForeName>Mitchell</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Warren Alpert Medical School, Brown University, Providence, RI 02912, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rothman</LastName><ForeName>Richard E</ForeName><Initials>RE</Initials><AffiliationInfo><Affiliation>School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>D'Alessio</LastName><ForeName>Franco R</ForeName><Initials>FR</Initials><AffiliationInfo><Affiliation>Pulmonary and Critical Care &amp; Sleep Medicine, Department of Medicine, University of Miami, Miami, FL 33136, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sidhaye</LastName><ForeName>Venkataramana K</ForeName><Initials>VK</Initials><AffiliationInfo><Affiliation>School of Medicine, Johns Hopkins University, Baltimore, MD 21205, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aggarwal</LastName><ForeName>Neil R</ForeName><Initials>NR</Initials><Identifier Source="ORCID">0000-0002-0922-8824</Identifier><AffiliationInfo><Affiliation>Anschutz Medical Campus, University of Colorado, Denver, CO 80045, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Greenberg</LastName><ForeName>Jared A</ForeName><Initials>JA</Initials><AffiliationInfo><Affiliation>Rush Medical College and Rush University Medical Center, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yoder</LastName><ForeName>Mark</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Rush Medical College and Rush University Medical Center, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Patel</LastName><ForeName>Gourang</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Rush Medical College and Rush University Medical Center, Chicago, IL 60612, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gilbert</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Loyola University Medical Center, Maywood, IL 60153, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Parada</LastName><ForeName>Jorge P</ForeName><Initials>JP</Initials><AffiliationInfo><Affiliation>Loyola University Medical Center, Maywood, IL 60153, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Afshar</LastName><ForeName>Majid</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>School of Medicine and Public Health, University of Wisconsin, Madison, WI 53705, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kempker</LastName><ForeName>Jordan A</ForeName><Initials>JA</Initials><Identifier Source="ORCID">0000-0002-6830-5201</Identifier><AffiliationInfo><Affiliation>Grady Memorial Hospital and Emory University School of Medicine, Atlanta, GA 30322, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van der Poll</LastName><ForeName>Tom</ForeName><Initials>T</Initials><AffiliationInfo><Affiliation>Amsterdam UMC, University of Amsterdam, 1105 AZ Amsterdam, The Netherlands.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Schultz</LastName><ForeName>Marcus J</ForeName><Initials>MJ</Initials><Identifier Source="ORCID">0000-0003-3969-7792</Identifier><AffiliationInfo><Affiliation>Division of Cardiothoracic and Vascular Anesthesia and Intensive Care Medicine, Department of Anesthesia, General Intensive Care, and Pain Management, Medical University of Vienna, 1090 Vienna, Austria.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Nuffield Department of Medicine, University of Oxford, Oxford OX1 2JD, UK.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Scicluna</LastName><ForeName>Brendon P</ForeName><Initials>BP</Initials><Identifier Source="ORCID">0000-0003-2826-0341</Identifier><AffiliationInfo><Affiliation>Centre for Molecular Medicine and Biobanking, University of Malta, Msida MSD 2080, Malta.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Applied Biomedical Science, Faculty of Health Sciences, Mater Dei Hospital, University of Malta, Msida MSD 2080, Malta.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Klein Klouwenberg</LastName><ForeName>Peter M C</ForeName><Initials>PMC</Initials><AffiliationInfo><Affiliation>Fundashon Mariadal, Kralendijk, Bonaire, Netherlands Antilles.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liebler</LastName><ForeName>Janice</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0002-4166-6197</Identifier><AffiliationInfo><Affiliation>Keck Hospital of University of Southern California (USC), Los Angeles, CA 90033, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Los Angeles General Medical Center, Los Angeles, CA 90033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Blodget</LastName><ForeName>Emily</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Keck Hospital of University of Southern California (USC), Los Angeles, CA 90033, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Los Angeles General Medical Center, Los Angeles, CA 90033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kumar</LastName><ForeName>Santhi</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Keck Hospital of University of Southern California (USC), Los Angeles, CA 90033, USA.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Los Angeles General Medical Center, Los Angeles, CA 90033, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mei</LastName><ForeName>Xue W</ForeName><Initials>XW</Initials><Identifier Source="ORCID">0000-0002-6279-4884</Identifier><AffiliationInfo><Affiliation>Princeton Pharmatech, Princeton, NJ 08540, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Navalkar</LastName><ForeName>Krupa</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-4751-6130</Identifier><AffiliationInfo><Affiliation>Immunexpress Inc., Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yager</LastName><ForeName>Thomas D</ForeName><Initials>TD</Initials><Identifier Source="ORCID">0000-0002-2341-2353</Identifier><AffiliationInfo><Affiliation>Immunexpress Inc., Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sampson</LastName><ForeName>Dayle</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Immunexpress Inc., Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kirk</LastName><ForeName>James T</ForeName><Initials>JT</Initials><AffiliationInfo><Affiliation>Immunexpress Inc., Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cermelli</LastName><ForeName>Silvia</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Immunexpress Inc., Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Davis</LastName><ForeName>Roy F</ForeName><Initials>RF</Initials><AffiliationInfo><Affiliation>Immunexpress Inc., Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Brandon</LastName><ForeName>Richard B</ForeName><Initials>RB</Initials><AffiliationInfo><Affiliation>Immunexpress Inc., Seattle, WA 98109, USA.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>10</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>J Clin Med</MedlineTA><NlmUniqueID>101606588</NlmUniqueID><ISSNLinking>2077-0383</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">SIRS</Keyword><Keyword MajorTopicYN="N">SeptiCyte</Keyword><Keyword MajorTopicYN="N">host immune response</Keyword><Keyword MajorTopicYN="N">phenotype</Keyword><Keyword MajorTopicYN="N">sepsis</Keyword><Keyword MajorTopicYN="N">sepsis likelihood</Keyword><Keyword MajorTopicYN="N">stratification</Keyword></KeywordList><CoiStatement>K.N., T.D.Y., D.S., J.T.K., S.C., R.F.D. and R.B.B. declare they are present or past employees or shareholders of Immunexpress, Inc. X.W.M. declares that she is a present employee of Princeton Pharmatech, Inc. R.R.M. III discloses that, over the time period of relevance to this work he was paid (as a consultant) an honorarium by Immunexpress for conducting a critical review of a Clinical Evaluation Report of SeptiCyte technology, submitted by Immunexpress to the Therapeutic Goods Administration (TGA) of Australia. N.R.A. declares that he has received grants from the NIH and Department of Defense for non-related work and that payments from these grants are made to his institution, the University of Colorado. N.R.A. also declares that he is a committee member of the Pfizer Paxlovid U.S. Medical Advisory Committee formed to broadly discuss COVID-19-related therapeutic priorities and populations of interest. B.K.L. declares that he is a consultant for Karius Inc., is a member of the Scientific Advisory Board for Seegene Inc., and has received honoraria for speaking for Qiagen Inc. No other competing interests are declared.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>9</Month><Day>2</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>10</Month><Day>8</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>23</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>19</Hour><Minute>22</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>26</Day><Hour>1</Hour><Minute>12</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>10</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39457994</ArticleId><ArticleId IdType="pmc">PMC11509035</ArticleId><ArticleId IdType="doi">10.3390/jcm13206044</ArticleId><ArticleId IdType="pii">jcm13206044</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Liu V.X., Bhimarao M., Greene J.D.M., Manickam R.N., Martinez A., Schuler A., Barreda F.M., Escobar G.J. The Presentation, Pace, and Profile of Infection and Sepsis Patients Hospitalized Through the Emergency Department: An Exploratory Analysis. Crit. Care Explor. 2021;3:e0344. doi: 10.1097/CCE.0000000000000344.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCE.0000000000000344</ArticleId><ArticleId IdType="pmc">PMC7909460</ArticleId><ArticleId IdType="pubmed">33655214</ArticleId></ArticleIdList></Reference><Reference><Citation>Lengquist M., Varadarajan A., Alestam S., Friberg H., Frigyesi A., Mellhammar L. Sepsis mimics among presumed sepsis patients at intensive care admission: A retrospective observational study. Infection. 2024;52:1041–1053. doi: 10.1007/s15010-023-02158-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-023-02158-w</ArticleId><ArticleId IdType="pubmed">38280062</ArticleId></ArticleIdList></Reference><Reference><Citation>Seymour C.W., Kennedy J.N., Wang S., Chang C.-C.H., Elliott C.F., Xu Z., Berry S., Clermont G., Cooper G., Gomez H., et al. Derivation, Validation, and Potential Treatment Implications of Novel Clinical Phenotypes for Sepsis. JAMA. 2019;321:2003–2017. doi: 10.1001/jama.2019.5791.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2019.5791</ArticleId><ArticleId IdType="pmc">PMC6537818</ArticleId><ArticleId IdType="pubmed">31104070</ArticleId></ArticleIdList></Reference><Reference><Citation>Fohner A.E., Greene J.D., Lawson B.L., Chen J.H., Kipnis P., Escobar G.J., Liu V.X. Assessing clinical heterogeneity in sepsis through treatment patterns and machine learning. J. Am. Med. Inform. Assoc. 2019;26:1466–1477. doi: 10.1093/jamia/ocz106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/jamia/ocz106</ArticleId><ArticleId IdType="pmc">PMC7647146</ArticleId><ArticleId IdType="pubmed">31314892</ArticleId></ArticleIdList></Reference><Reference><Citation>Reddy K., Sinha P., O’Kane C.M., Gordon A.C., Calfee C.S., McAuley D.F. Subphenotypes in critical care: Translation into clinical practice. Lancet Respir. Med. 2020;8:631–643. doi: 10.1016/S2213-2600(20)30124-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(20)30124-7</ArticleId><ArticleId IdType="pubmed">32526190</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopansri B.K., Miller R.R., III, Burke J.P., Levy M., Opal S., Rothman R.E., D’alessio F.R., Sidhaye V.K., Balk R., Greenberg J.A., et al. Physician agreement on the diagnosis of sepsis in the intensive care unit: Estimation of concordance and analysis of underlying factors in a multicenter cohort. J. Intensiv. Care. 2019;7:13. doi: 10.1186/s40560-019-0368-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40560-019-0368-2</ArticleId><ArticleId IdType="pmc">PMC6383290</ArticleId><ArticleId IdType="pubmed">30828456</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhavani S.V., Semler M., Qian E.T., Verhoef P.A., Robichaux C., Churpek M.M., Coopersmith C.M. Development and validation of novel sepsis subphenotypes using trajectories of vital signs. Intensiv. Care Med. 2022;48:1582–1592. doi: 10.1007/s00134-022-06890-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-022-06890-z</ArticleId><ArticleId IdType="pmc">PMC9510534</ArticleId><ArticleId IdType="pubmed">36152041</ArticleId></ArticleIdList></Reference><Reference><Citation>Sinha P., Kerchberger V.E., Willmore A., Chambers J., Zhuo H., Abbott J., Jones C., Wickersham N., Wu N., Neyton L., et al. Identifying molecular phenotypes in sepsis: An analysis of two prospective observational cohorts and secondary analysis of two randomised controlled trials. Lancet Respir. Med. 2023;11:965–974. doi: 10.1016/S2213-2600(23)00237-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(23)00237-0</ArticleId><ArticleId IdType="pmc">PMC10841178</ArticleId><ArticleId IdType="pubmed">37633303</ArticleId></ArticleIdList></Reference><Reference><Citation>E Davenport E., Burnham K.L., Radhakrishnan J., Humburg P., Hutton P., Mills T.C., Rautanen A., Gordon A.C., Garrard C., Hill A.V.S., et al. Genomic landscape of the individual host response and outcomes in sepsis: A prospective cohort study. Lancet Respir. Med. 2016;4:259–271. doi: 10.1016/S2213-2600(16)00046-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(16)00046-1</ArticleId><ArticleId IdType="pmc">PMC4820667</ArticleId><ArticleId IdType="pubmed">26917434</ArticleId></ArticleIdList></Reference><Reference><Citation>Scicluna B.P., van Vught L.A., Zwinderman A.H., Wiewel M.A., Davenport E.E., Burnham K.L., Nürnberg P., Schultz M.J., Horn J., Cremer O.L., et al. Classification of patients with sepsis according to blood genomic endotype: A prospective cohort study. Lancet Respir. Med. 2017;5:816–826. doi: 10.1016/S2213-2600(17)30294-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(17)30294-1</ArticleId><ArticleId IdType="pubmed">28864056</ArticleId></ArticleIdList></Reference><Reference><Citation>Sweeney T.E., Azad T.D., Donato M., Haynes W.A., Perumal T.M., Henao R., Bermejo-Martin J.F., Almansa R., Tamayo E., Howrylak J.A., et al. Unsupervised Analysis of Transcriptomics in Bacterial Sepsis Across Multiple Datasets Reveals Three Robust Clusters. Crit. Care Med. 2018;46:915–925. doi: 10.1097/CCM.0000000000003084.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000003084</ArticleId><ArticleId IdType="pmc">PMC5953807</ArticleId><ArticleId IdType="pubmed">29537985</ArticleId></ArticleIdList></Reference><Reference><Citation>DeMerle K.M., Angus D.C., Baillie J.K., Brant E., Calfee C.S.M., Carcillo J., Chang C.-C.H., Dickson R., Evans I.M., Gordon A.C., et al. Sepsis Subclasses: A Framework for Development and Interpretation*. Crit. Care Med. 2021;49:748–759. doi: 10.1097/CCM.0000000000004842.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000004842</ArticleId><ArticleId IdType="pmc">PMC8627188</ArticleId><ArticleId IdType="pubmed">33591001</ArticleId></ArticleIdList></Reference><Reference><Citation>Coburn B., Morris A.M., Tomlinson G., Detsky A.S. Does This Adult Patient with Suspected Bacteremia Require Blood Cultures? JAMA. 2012;308:502–511. doi: 10.1001/jama.2012.8262. doi: 10.1001/jama.2012.210984. Erratum in JAMA 2013, 309, 343.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2012.8262</ArticleId><ArticleId IdType="doi">10.1001/jama.2012.210984</ArticleId><ArticleId IdType="pubmed">22851117</ArticleId></ArticleIdList></Reference><Reference><Citation>Vincent J.-L., Bogossian E., Menozzi M. The Future of Biomarkers. Crit. Care Clin. 2020;36:177–187. doi: 10.1016/j.ccc.2019.08.014.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2019.08.014</ArticleId><ArticleId IdType="pubmed">31733679</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R.R., III, Lopansri B.K., Burke J.P., Levy M., Opal S., Rothman R.E., D’alessio F.R., Sidhaye V.K., Aggarwal N.R., Balk R., et al. Validation of a Host Response Assay, SeptiCyte LAB, for Discriminating Sepsis from Systemic Inflammatory Response Syndrome in the ICU. Am. J. Respir. Crit. Care Med. 2018;198:903–913. doi: 10.1164/rccm.201712-2472OC. doi: 10.1164/rccm.v202erratum2. Erratum in Am. J. Respir. Crit. Care Med. 2020, 202, 155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201712-2472OC</ArticleId><ArticleId IdType="doi">10.1164/rccm.v202erratum2</ArticleId><ArticleId IdType="pmc">PMC6835074</ArticleId><ArticleId IdType="pubmed">29624409</ArticleId></ArticleIdList></Reference><Reference><Citation>Balk R., Esper A.M., Martin G.S., Miller R.R., III, Lopansri B.K., Burke J.P., Levy M., Opal S., Rothman R.E., D’alessio F.R., et al. Validation of SeptiCyte RAPID to Discriminate Sepsis from Non-Infectious Systemic Inflammation. J. Clin. Med. 2024;13:1194. doi: 10.3390/jcm13051194.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/jcm13051194</ArticleId><ArticleId IdType="pmc">PMC10931699</ArticleId><ArticleId IdType="pubmed">38592057</ArticleId></ArticleIdList></Reference><Reference><Citation>McHugh L., Seldon T.A., Brandon R.A., Kirk J.T., Rapisarda A., Sutherland A.J., Presneill J.J., Venter D.J., Lipman J., Thomas M.R., et al. A Molecular Host Response Assay to Discriminate Between Sepsis and Infection-Negative Systemic Inflammation in Critically Ill Patients: Discovery and Validation in Independent Cohorts. PLoS Med. 2015;12:e1001916. doi: 10.1371/journal.pmed.1001916.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001916</ArticleId><ArticleId IdType="pmc">PMC4672921</ArticleId><ArticleId IdType="pubmed">26645559</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team  . R: A Language and Environment for Statistical Computing. R Foundation for Statistical Computing; Vienna, Austria: 2024.  [(accessed on 1 September 2024)].  Available online:  http://www.R-project.org/</Citation></Reference><Reference><Citation>Robin X., Turck N., Hainard A., Tiberti N., Lisacek F., Sanchez J.-C., Müller M. pROC: An open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinform. 2011;12:77. doi: 10.1186/1471-2105-12-77.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2105-12-77</ArticleId><ArticleId IdType="pmc">PMC3068975</ArticleId><ArticleId IdType="pubmed">21414208</ArticleId></ArticleIdList></Reference><Reference><Citation>Hanley J.A., McNeil B.J. The meaning and use of the area under a receiver operating characteristic (ROC) curve. Radiology. 1982;143:29–36. doi: 10.1148/radiology.143.1.7063747.</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiology.143.1.7063747</ArticleId><ArticleId IdType="pubmed">7063747</ArticleId></ArticleIdList></Reference><Reference><Citation>Delong E.R., Delong D.M., Clarke-Pearson D.L. Comparing the Areas under Two or More Correlated Receiver Operating Characteristic Curves: A Nonparametric Approach. Biometrics. 1988;44:837–845. doi: 10.2307/2531595.</Citation><ArticleIdList><ArticleId IdType="doi">10.2307/2531595</ArticleId><ArticleId IdType="pubmed">3203132</ArticleId></ArticleIdList></Reference><Reference><Citation>Skalsk’a H., Freylich V. Web-Bootstrap Estimate of Area Under ROC Curve. Austrian J. Stat. 2006;35:325–330. doi: 10.17713/ajs.v35i2&amp;3.379.</Citation><ArticleIdList><ArticleId IdType="doi">10.17713/ajs.v35i2&amp;3.379</ArticleId></ArticleIdList></Reference><Reference><Citation>Mason S.J., Graham N.E. Areas beneath the relative operating characteristics (ROC) and relative operating levels (ROL) curves: Statistical significance and interpretation. Q. J. R. Meteorol. Soc. 2002;128:2145–2166. doi: 10.1256/003590002320603584.</Citation><ArticleIdList><ArticleId IdType="doi">10.1256/003590002320603584</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu W., Dai J., Hung Y.S., Wang Q. Estimating the area under a receiver operating characteristic (ROC) curve: Parametric and nonparametric ways. Signal Process. 2013;93:3111–3123. doi: 10.1016/j.sigpro.2013.05.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sigpro.2013.05.010</ArticleId></ArticleIdList></Reference><Reference><Citation>Ghasemi A., Zahediasl S. Normality Tests for Statistical Analysis: A Guide for Non-Statisticians. Int. J. Endocrinol. Metab. 2012;10:486–489. doi: 10.5812/ijem.3505.</Citation><ArticleIdList><ArticleId IdType="doi">10.5812/ijem.3505</ArticleId><ArticleId IdType="pmc">PMC3693611</ArticleId><ArticleId IdType="pubmed">23843808</ArticleId></ArticleIdList></Reference><Reference><Citation>Lê S., Josse J., Husson F. FactoMineR: An R Package for Multivariate Analysis. J. Stat. Softw. 2008;25:1–18. doi: 10.18637/jss.v025.i01.</Citation><ArticleIdList><ArticleId IdType="doi">10.18637/jss.v025.i01</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang C., Yang K., Zhou B. A hierarchical Clustering Method Based on PCA-Clusters Merging for Quasi-linear SVM; Proceedings of the 2015 International Conference on Automation, Mechanical Control and Computational Engineering; Changsha, China. 24–25 October 2015.</Citation></Reference><Reference><Citation>Maugeri A., Barchitta M., Basile G., Agodi A. Applying a hierarchical clustering on principal components approach to identify different patterns of the SARS-CoV-2 epidemic across Italian regions. Sci. Rep. 2021;11:7082. doi: 10.1038/s41598-021-86703-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-86703-3</ArticleId><ArticleId IdType="pmc">PMC8007710</ArticleId><ArticleId IdType="pubmed">33782519</ArticleId></ArticleIdList></Reference><Reference><Citation>Koh K.-Y., Ahmad S., Lee J.-I., Suh G.-H., Lee C.-M. Hierarchical Clustering on Principal Components Analysis to Detect Clusters of Highly Pathogenic Avian Influenza Subtype H5N6 Epidemic across South Korean Poultry Farms. Symmetry. 2022;14:598. doi: 10.3390/sym14030598.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/sym14030598</ArticleId></ArticleIdList></Reference><Reference><Citation>Ikotun A.M., Ezugwu A.E., Abualigah L., Abuhaija B., Heming J. K-means clustering algorithms: A comprehensive review, variants analysis, and advances in the era of big data. Inf. Sci. 2023;622:178–210. doi: 10.1016/j.ins.2022.11.139.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ins.2022.11.139</ArticleId></ArticleIdList></Reference><Reference><Citation>Rousseeuw P.J. Silhouettes: A graphical aid to the interpretation and validation of cluster analysis. J. Comput. Appl. Math. 1987;20:53–65. doi: 10.1016/0377-0427(87)90125-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0377-0427(87)90125-7</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu J., Gan Q., Zhou D., Xia X., Xiang W., Xiao R., Tang J., Li J. Evaluating the risk of sepsis attributing to obesity: A two-sample Mendelian randomization study. Postgrad. Med. J. 2023;99:1266–1271. doi: 10.1093/postmj/qgad072.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/postmj/qgad072</ArticleId><ArticleId IdType="pubmed">37681245</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J., Hu Y., Zeng J., Li Q., He L., Hao W., Song X., Yan S., Lv C. Exploring the Causality Between Body Mass Index and Sepsis: A Two-Sample Mendelian Randomization Study. Int. J. Public Health. 2023;68:1605548. doi: 10.3389/ijph.2023.1605548.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/ijph.2023.1605548</ArticleId><ArticleId IdType="pmc">PMC10186272</ArticleId><ArticleId IdType="pubmed">37205044</ArticleId></ArticleIdList></Reference><Reference><Citation>Peri A.M., Rafiei N., O’callaghan K., Brischetto A., Graves B., Sinclair H., Eustace M., Lim K., Parkes-Smith J., Stewart A., et al. Host response signature trends in persistent bacteraemia and metastatic infection due to Staphylococcus aureus and Gram-negative bacilli: A prospective multicentre observational study. Infect. Dis. 2024;56:268–276. doi: 10.1080/23744235.2023.2294122.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2023.2294122</ArticleId><ArticleId IdType="pubmed">38093600</ArticleId></ArticleIdList></Reference><Reference><Citation>Papathanakos G., Andrianopoulos I., Xenikakis M., Papathanasiou A., Koulenti D., Blot S., Koulouras V. Clinical Sepsis Phenotypes in Critically Ill Patients. Microorganisms. 2023;11:2165. doi: 10.3390/microorganisms11092165.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/microorganisms11092165</ArticleId><ArticleId IdType="pmc">PMC10538192</ArticleId><ArticleId IdType="pubmed">37764009</ArticleId></ArticleIdList></Reference><Reference><Citation>DiMeglio M., Dubensky J., Schadt S., Potdar R., Laudanski K. Factors Underlying Racial Disparities in Sepsis Management. Healthcare. 2018;6:133. doi: 10.3390/healthcare6040133.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/healthcare6040133</ArticleId><ArticleId IdType="pmc">PMC6315577</ArticleId><ArticleId IdType="pubmed">30463180</ArticleId></ArticleIdList></Reference><Reference><Citation>Guillamet M.C.V., Dodda S., Liu L., Kollef M.H., Micek S.T. Race Does Not Impact Sepsis Outcomes When Considering Socioeconomic Factors in Multilevel Modeling. Crit. Care Med. 2022;50:410–417. doi: 10.1097/CCM.0000000000005217.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0000000000005217</ArticleId><ArticleId IdType="pmc">PMC9366968</ArticleId><ArticleId IdType="pubmed">34259658</ArticleId></ArticleIdList></Reference><Reference><Citation>Frydrych L.M., Fattahi F., He K., Ward P.A., Delano M.J. Diabetes and Sepsis: Risk, Recurrence, and Ruination. Front. Endocrinol. 2017;8:271. doi: 10.3389/fendo.2017.00271.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fendo.2017.00271</ArticleId><ArticleId IdType="pmc">PMC5670360</ArticleId><ArticleId IdType="pubmed">29163354</ArticleId></ArticleIdList></Reference><Reference><Citation>Carey I.M., Critchley J.A., DeWilde S., Harris T., Hosking F.J., Cook D.G. Risk of Infection in Type 1 and Type 2 Diabetes Compared with the General Population: A Matched Cohort Study. Diabetes Care. 2018;41:513–521. doi: 10.2337/dc17-2131.</Citation><ArticleIdList><ArticleId IdType="doi">10.2337/dc17-2131</ArticleId><ArticleId IdType="pubmed">29330152</ArticleId></ArticleIdList></Reference><Reference><Citation>Ahlberg C.D., Wallam S., Tirba L.A., Itumba S.N., Gorman L., Galiatsatos P. Linking Sepsis with chronic arterial hypertension, diabetes mellitus, and socioeconomic factors in the United States: A scoping review. J. Crit. Care. 2023;77:154324. doi: 10.1016/j.jcrc.2023.154324.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jcrc.2023.154324</ArticleId><ArticleId IdType="pubmed">37159971</ArticleId></ArticleIdList></Reference><Reference><Citation>Doi K., Leelahavanichkul A., Hu X., Sidransky K.L., Zhou H., Qin Y., Eisner C., Schnermann J., Yuen P.S., Star R.A. Pre-existing renal disease promotes sepsis-induced acute kidney injury and worsens outcome. Kidney Int. 2008;74:1017–1025. doi: 10.1038/ki.2008.346.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/ki.2008.346</ArticleId><ArticleId IdType="pmc">PMC2614371</ArticleId><ArticleId IdType="pubmed">18633340</ArticleId></ArticleIdList></Reference><Reference><Citation>Ou S.-M., Lee K.-H., Tsai M.-T., Tseng W.-C., Chu Y.-C., Tarng D.-C. Sepsis and the Risks of Long-Term Renal Adverse Outcomes in Patients with Chronic Kidney Disease. Front. Med. 2022;9:809292. doi: 10.3389/fmed.2022.809292.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.809292</ArticleId><ArticleId IdType="pmc">PMC8908417</ArticleId><ArticleId IdType="pubmed">35280875</ArticleId></ArticleIdList></Reference><Reference><Citation>Gudiol C., Albasanz-Puig A., Cuervo G., Carratalà J. Understanding and Managing Sepsis in Patients with Cancer in the Era of Antimicrobial Resistance. Front. Med. 2021;8:636547. doi: 10.3389/fmed.2021.636547.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.636547</ArticleId><ArticleId IdType="pmc">PMC8044357</ArticleId><ArticleId IdType="pubmed">33869250</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakada T.-A., Takahashi W., Nakada E., Shimada T., Russell J.A., Walley K.R. Genetic Polymorphisms in Sepsis and Cardiovascular Disease: Do Similar Risk Genes Suggest Similar Drug Targets? Chest. 2019;155:1260–1271. doi: 10.1016/j.chest.2019.01.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2019.01.003</ArticleId><ArticleId IdType="pubmed">30660782</ArticleId></ArticleIdList></Reference><Reference><Citation>Cavaillon J.-M., Chousterman B.G., Skirecki T. Compartmentalization of the inflammatory response during bacterial sepsis and severe COVID-19. J. Intensiv. Med. 2024;4:326–340. doi: 10.1016/j.jointm.2024.01.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jointm.2024.01.001</ArticleId><ArticleId IdType="pmc">PMC11258514</ArticleId><ArticleId IdType="pubmed">39035623</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen Q.-T., Nguyen T.-H.T., Ju S.-A., Lee Y.-S., Han S.H., Lee S.-C., Kwon B.S., Yu R., Kim G.Y., Lee B.J., et al. CD137 Expressed on Neutrophils Plays Dual Roles in Antibacterial Responses against Gram-Positive and Gram-Negative Bacterial Infections. Infect. Immun. 2013;81:2168–2177. doi: 10.1128/IAI.00115-13.</Citation><ArticleIdList><ArticleId IdType="doi">10.1128/IAI.00115-13</ArticleId><ArticleId IdType="pmc">PMC3676019</ArticleId><ArticleId IdType="pubmed">23545301</ArticleId></ArticleIdList></Reference><Reference><Citation>Roger P.-M., Keïta-Perse O., Mainardi J.-L. Diagnostic uncertainty in infectious diseases: Advocacy for a nosological framework. Infect. Dis. Now. 2023;53:104751. doi: 10.1016/j.idnow.2023.104751.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.idnow.2023.104751</ArticleId><ArticleId IdType="pubmed">37422197</ArticleId></ArticleIdList></Reference><Reference><Citation>Takiguchi H., Chen V., Obeidat M., Hollander Z., FitzGerald J.M., McManus B.M., Ng R.T., Sin D.D. Effect of short-term oral prednisone therapy on blood gene expression: A randomised controlled clinical trial. Respir. Res. 2019;20:176–210. doi: 10.1186/s12931-019-1147-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-019-1147-2</ArticleId><ArticleId IdType="pmc">PMC6683462</ArticleId><ArticleId IdType="pubmed">31382977</ArticleId></ArticleIdList></Reference><Reference><Citation>Chinenov Y., Coppo M., Gupte R., A Sacta M., Rogatsky I. Glucocorticoid receptor coordinates transcription factor-dominated regulatory network in macrophages. BMC Genom. 2014;15:656. doi: 10.1186/1471-2164-15-656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2164-15-656</ArticleId><ArticleId IdType="pmc">PMC4133603</ArticleId><ArticleId IdType="pubmed">25099603</ArticleId></ArticleIdList></Reference><Reference><Citation>Gupta S., Sakhuja A., Kumar G., McGrath E., Nanchal R.S., Kashani K.B. Culture-Negative Severe Sepsis: Nationwide Trends and Outcomes. Chest. 2016;150:1251–1259. doi: 10.1016/j.chest.2016.08.1460.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2016.08.1460</ArticleId><ArticleId IdType="pubmed">27615024</ArticleId></ArticleIdList></Reference><Reference><Citation>Hirosawa T., Sakamoto T., Hanai S., Harada Y., Shimizu T. Effect of Prior Antibiotic Treatment on Blood Culture in an Outpatient Department of General Internal Medicine: A Retrospective Case–Control Analysis. Int. J. Gen. Med. 2023;16:2709–2717. doi: 10.2147/IJGM.S416235.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IJGM.S416235</ArticleId><ArticleId IdType="pmc">PMC10317762</ArticleId><ArticleId IdType="pubmed">37408849</ArticleId></ArticleIdList></Reference><Reference><Citation>Rhee C., Kadri S.S., Danner R.L., Suffredini A.F., Massaro A.F., Kitch B.T., Lee G., Klompas M. Diagnosing sepsis is subjective and highly variable: A survey of intensivists using case vignettes. Crit. Care. 2016;20:1–89. doi: 10.1186/s13054-016-1266-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-016-1266-9</ArticleId><ArticleId IdType="pmc">PMC4822273</ArticleId><ArticleId IdType="pubmed">27048508</ArticleId></ArticleIdList></Reference><Reference><Citation>Opal S.M., Wittebole X. Biomarkers of Infection and Sepsis. Crit. Care Clin. 2020;36:11–22. doi: 10.1016/j.ccc.2019.08.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ccc.2019.08.002</ArticleId><ArticleId IdType="pubmed">31733673</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierrakos C., Velissaris D., Bisdorff M., Marshall J.C., Vincent J.-L. Biomarkers of sepsis: Time for a reappraisal. Crit. Care. 2020;24:287. doi: 10.1186/s13054-020-02993-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02993-5</ArticleId><ArticleId IdType="pmc">PMC7273821</ArticleId><ArticleId IdType="pubmed">32503670</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu V.X., Fielding-Singh V., Greene J.D., Baker J.M., Iwashyna T.J., Bhattacharya J., Escobar G.J. The Timing of Early Antibiotics and Hospital Mortality in Sepsis. Am. J. Respir. Crit. Care Med. 2017;196:856–863. doi: 10.1164/rccm.201609-1848OC.</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/rccm.201609-1848OC</ArticleId><ArticleId IdType="pmc">PMC5649973</ArticleId><ArticleId IdType="pubmed">28345952</ArticleId></ArticleIdList></Reference><Reference><Citation>Umemura Y., Abe T., Ogura H., Fujishima S., Kushimoto S., Shiraishi A., Saitoh D., Mayumi T., Otomo Y., Hifumi T., et al. Hour-1 bundle adherence was associated with reduction of in-hospital mortality among patients with sepsis in Japan. PLoS ONE. 2022;17:e0263936. doi: 10.1371/journal.pone.0263936.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0263936</ArticleId><ArticleId IdType="pmc">PMC8843226</ArticleId><ArticleId IdType="pubmed">35157744</ArticleId></ArticleIdList></Reference><Reference><Citation>Evans L., Rhodes A., Alhazzani W., Antonelli M., Coopersmith C.M., French C., Machado F.R., Mcintyre L., Ostermann M., Prescott H.C., et al. Surviving sepsis campaign: International guidelines for management of sepsis and septic shock 2021. Intensiv. Care Med. 2021;47:1181–1247. doi: 10.1007/s00134-021-06506-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-021-06506-y</ArticleId><ArticleId IdType="pmc">PMC8486643</ArticleId><ArticleId IdType="pubmed">34599691</ArticleId></ArticleIdList></Reference><Reference><Citation>Cohen J. A Coefficient of Agreement for Nominal Scales. Educ. Psychol. Meas. 1960;20:213–220. doi: 10.1177/001316446002000104.</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/001316446002000104</ArticleId></ArticleIdList></Reference><Reference><Citation>Fleiss J.L., Cohen J., Everitt B.S. Large sample standard errors of kappa and weighted kappa. Psychol. Bull. 1969;72:323–327. doi: 10.1037/h0028106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1037/h0028106</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein-Greenwood J., (UVA Library StatLab)  ROC Curves and AUC for Models Used for Binary Classification. 2022.  [(accessed on 19 August 2024)].  Available online:  https://library.virginia.edu/data/articles/roc-curves-and-auc-for-models-used-for-binary-classification.</Citation></Reference><Reference><Citation>Kuye I., Anand V., Klompas M., Chan C., Kadri S.S., Rhee C. Prevalence and Clinical Characteristics of Patients with Sepsis Discharge Diagnosis Codes and Short Lengths of Stay in U.S. Hospitals. Crit. Care Explor. 2021;3:e0373. doi: 10.1097/CCE.0000000000000373.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCE.0000000000000373</ArticleId><ArticleId IdType="pmc">PMC7994044</ArticleId><ArticleId IdType="pubmed">33786449</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin C., Zhang S., Zhao Y., Ding X., Yang F., Zhao Y. Diagnostic value of metagenomic next-generation sequencing in sepsis and bloodstream infection. Front. Cell. Infect. Microbiol. 2023;13:1117987. doi: 10.3389/fcimb.2023.1117987.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2023.1117987</ArticleId><ArticleId IdType="pmc">PMC9950395</ArticleId><ArticleId IdType="pubmed">36844396</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoonjans F. MedCalc Manual: Easy-to-Use Statistical Software. MedCalc Software bvba; Ostend, Belgium: 2017.</Citation></Reference><Reference><Citation>Yang L., Lin Y., Wang J., Song J., Wei B., Zhang X., Yang J., Liu B. Comparison of Clinical Characteristics and Outcomes Between Positive and Negative Blood Culture Septic Patients: A Retrospective Cohort Study. Infect. Drug Resist. 2021;14:4191–4205. doi: 10.2147/IDR.S334161.</Citation><ArticleIdList><ArticleId IdType="doi">10.2147/IDR.S334161</ArticleId><ArticleId IdType="pmc">PMC8520438</ArticleId><ArticleId IdType="pubmed">34675564</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou X.H., Obuchowski N.A., McClish D.K. Statistical Methods in Diagnostic Medicine. 2nd ed. John Wiley and Sons; Hoboken, NJ, USA: 2011.</Citation></Reference><Reference><Citation>Zweig M.H., Campbell G. Receiver-operating characteristic (ROC) plots: A fundamental evaluation tool in clinical medicine. Clin. Chem. 1993;39:561–577. doi: 10.1093/clinchem/39.4.561. Erratum in Clin. Chem. 1993, 39, 1589. https://doi.org/10.1093/clinchem/39.8.1589.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/clinchem/39.4.561</ArticleId><ArticleId IdType="pubmed">8472349</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>